Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Exercise of Options

7 Dec 2017 07:00

RNS Number : 6262Y
Versarien PLC
07 December 2017
 

7 December 2017

Versarien plc

("Versarien" or the "Company")

Exercise of Options

Director/PDMR Shareholding

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has issued 910,900 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise by directors and an employee of the Company under the Company's share option schemes.

Named person

No. options exercised

Exercise price per share

Neill Ricketts

250,000

12.25p

Chris Leigh

528,720

15.50p

Employee (non-PDMR)

132,180

12.25p

Total

910,900

 

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 11 December 2017. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

The Company was also notified that Christopher Leigh, Chief Financial Officer has sold 528,720 Ordinary Shares at an average price of 73.81 pence per Ordinary Share.

Following the transactions outlined above:

Mr Ricketts' interest in the share capital of the Company has increased to a total of 15,625,000 Ordinary Shares representing 10.53 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Ricketts is further interested in 278,720 options exercisable at 12.25 pence per share together with 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share; and

Mr Leigh's interest in the share capital of the Company has remained at a total of 315,000 Ordinary Shares representing 0.21 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Leigh is further interested in 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share.

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 148,386,309 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 148,386,309 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe / Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neill Ricketts

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

12.25p

250,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

250,000

ÂŁ30,625

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher Leigh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise and sale of options

c)

Price(s) and volume(s)

Exercise:

Price(s)

Volume(s)

15.50p

528,720

 

Sale:

Price(s)

Volume(s)

74.00p

73.64p

250,000

278,720

 

d)

Aggregated information

- Aggregated volume

- Price

 

- Aggregated volume

- Price

 Exercise:

528,720

ÂŁ81,952

Sale:

528,720

ÂŁ390,249

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADPCBDDQBK
Date   Source Headline
15th Jan 20187:00 amRNSPlanned Chinese graphene manufacturing facility
8th Jan 20187:00 amRNSAgreement with Global Apparel Manufacturer
5th Jan 201811:05 amRNSDirector/PDMR Shareholding
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
7th Dec 20177:00 amRNSExercise of Options
4th Dec 201711:05 amRNSSecond Price Monitoring Extn
4th Dec 201711:00 amRNSPrice Monitoring Extension
4th Dec 20179:00 amRNSPrice Monitoring Extension
4th Dec 20177:00 amRNSAgreement with Global Chemical Major
1st Dec 20172:05 pmRNSSecond Price Monitoring Extn
1st Dec 20172:00 pmRNSPrice Monitoring Extension
29th Nov 20177:00 amRNSInterim Results
28th Nov 20172:05 pmRNSSecond Price Monitoring Extn
28th Nov 20172:00 pmRNSPrice Monitoring Extension
21st Nov 20179:05 amRNSSecond Price Monitoring Extn
21st Nov 20179:00 amRNSPrice Monitoring Extension
17th Nov 20177:00 amRNSCollaboration with Global Consumer Goods Company
7th Nov 20174:40 pmRNSSecond Price Monitoring Extn
7th Nov 20174:35 pmRNSPrice Monitoring Extension
7th Nov 20173:07 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSSuccessful Fundraising of £2.9 million
3rd Nov 20174:43 pmRNSFundraising of approximately £1.2 million
3rd Nov 20174:40 pmRNSTrading Update and Notice of Results
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20172:05 pmRNSSecond Price Monitoring Extn
31st Oct 20172:00 pmRNSPrice Monitoring Extension
31st Oct 20177:00 amRNSCollaboration with Israel Aerospace Industries
2nd Oct 20177:00 amRNSAward of Share Options to Directors
22nd Sep 20171:11 pmRNSDirector/PDMR Shareholding
21st Sep 20179:38 amRNSHolding(s) in Company
20th Sep 20179:00 amRNSHolding(s) in Company
19th Sep 201711:01 amRNSHolding(s) in Company
19th Sep 201711:00 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSSignificant Tender Win
14th Sep 20176:03 pmRNSHolding(s) in Company
13th Sep 201711:45 amRNSResult of AGM
12th Sep 201712:26 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSHolding(s) in Company
11th Sep 20178:09 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSContract Win
1st Sep 20177:00 amRNSHolding(s) in Company
23rd Aug 20173:45 pmRNSHolding(s) in Company
9th Aug 201710:30 amRNSNotice of AGM
3rd Jul 20177:00 amRNSFinal Results for the year ended 31 March 2017
20th Apr 20177:00 amRNSInvestor Event
20th Apr 20177:00 amRNSResignation of Director
6th Apr 201711:13 amRNSHolding(s) in Company
4th Apr 20173:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.